In a bold move, U.S. President Donald Trump linked the fentanyl issue to his tariffs on Chinese imports, prompting a swift response from China. The Chinese government countered by detailing its efforts to combat the illegal fentanyl trade, expressing dismay at the imposition of tariffs in response to their goodwill gestures. Foreign Minister Wang Yi emphasized that responding to cooperation with tariffs is unjust, urging for a more responsible approach from major countries.

Trump’s executive order cited China for subsidizing chemical companies involved in fentanyl production and providing a safe harbor for criminal organizations laundering profits from the opioid trade. Despite bilateral efforts, the flow of precursor chemicals to criminal cartels remains unresolved, leading to the imposition of tariffs.

In response to U.S. tariffs, China retaliated with duties on selected U.S. products, aiming to prevent an escalation of the trade war that could harm the Chinese economy further. China emphasized its commitment to cooperation on fentanyl issues while opposing what it perceives as unjust sanctions and pressure from the U.S.

The article also highlights the shift in U.S.-China relations on fentanyl cooperation, from former President Joe Biden’s efforts to Trump’s current stance. Despite efforts to mend relations under Biden, Trump’s return to the White House signals a different approach to the U.S.-China dynamic. China has indicated a firm resolve against further escalation, setting the stage for potential ongoing challenges in the trade relationship.